Successful treatment of refractory TAFRO syndrome with elevated vascular endothelial growth factor using thyroxine supplements

Although the clinical significance of hypothyroidism in TAFRO syndrome is unknown, vascular endothelial growth factor (VEGF) levels decreased with improvements in the condition of our refractory TAFRO cases after thyroxine supplement therapy. Our results indicate that elevated VEGF levels are a pote...

Descripción completa

Detalles Bibliográficos
Autores principales: Oka, Satoko, Ono, Kazuo, Nohgawa, Masaharu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2018
Materias:
Case Reports
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5889265/
https://www.ncbi.nlm.nih.gov/pubmed/29636932
http://dx.doi.org/10.1002/ccr3.1430

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5889265/
https://www.ncbi.nlm.nih.gov/pubmed/29636932
http://dx.doi.org/10.1002/ccr3.1430

Ejemplares similares